BACKGROUND A puzzling feature of the long QT syndrome (LQTS) is that family members carrying the same mutation
proves problematic for physicians caring for these patients.
Over the last decade, this challenge prompted numerous attempts to identify "modifier genes," genetic variants associated with a higher or lower arrhythmic risk (2, 5) .
The current view holds that these modifiers include factors that either modify the underlying arrhythmogenic myocardial substrate or affect the probability and magnitude of arrhythmia-triggering events (2) . The former include proteins that likely contribute to the balance of inward and outward currents operating during the cardiac action potential, and several of these have already been identified (6) (7) (8) (9) (10) , and the latter include genes modulating differences in sympathetic and vagal responses (11) (12) (13) .
The present study aimed at expanding the understanding of the relationship between neural control and arrhythmic risk in LQTS. Two concepts, preliminary for the design of our study, were: 1) the focus should be on patients with LQTS type 1 (LQT1) because they are at risk specifically during sympathetic activation (14) ; and 2) these patients with LQT1
should all be from a single founder population and thus have the same mutation to avoid the phenotypic variability attributed to mutation heterogeneity.
Founder populations represent the ideal human model to study modifier genes (6) .
We previously showed that LQT1 asymptomatic mutation carriers (AMCs) were more likely to have a lower heart rate (11), lower baroreflex sensitivity (11) , and smaller heart rate decrease at the end of an exercise stress test than symptomatic mutation carriers (SMCs) (12) . The last 2 findings point to a protective effect of reduced vagal reflexes. A limitation of our studies is that although they provided novel data about vagal control in patients with LQTS, we had no specific information on the sympathetic control at the ventricular level.
Analysis of the spontaneous changes of the heart period and QT interval provides indexes that allow noninvasive inferences on the autonomic modulation directed to the sinus node and the ventricles (15) (16) (17) .
The power of the respiratory-related heart period changes in the high-frequency band (HF) (0.15 to 0.5 Hz) decreases with the vagal withdrawal progressively induced by graded head-up tilt (18) (19) (20) . By contrast, the magnitude of fluctuations of the QT interval in the low-frequency band (LF; 0.04 to 0.15 Hz) positively correlates with the inclination of the tilt table (21, 22) , suggesting that QT variability and sympathetic control are directly linked (23, 24) . The combination of these 2 indexes (i.e., the HF power of heart period variability and the LF power of QT variability) provides a unique possibility to dissect vagal and sympathetic influences on the heart and to test whether different autonomic patterns might help distinguish AMCs and SMCs.
We tested this hypothesis in a well-characterized LQT1 South African founder population in which all the affected members carry KCNQ1 A341V, one of the LQTS mutations with the most severe phenotype (25) (26) (27) . This relatively common mutation (26) produces a 50% reduction in basal I Ks current and in vitro severe reduction in cAMP responsiveness due to failure to phosphorylate KCNQ1 at the N-terminal S27 (28) .
METHODS
STUDY POPULATION AND PROTOCOL. The study population only included members of the 25 families constituting the South African LQT1 founder population carrying the KCNQ1 A341V mutation (25) (26) (27) . VARIABILITY SERIES EXTRACTION AND DATA ANALYSIS. Electrocardiogram (ECG) recordings were pre-processed to limit broadband noise and cancel baseline wandering (29) . Heart period was approximated as the temporal distance between 2 consecutive R-wave peaks (RR) on the ECG. The R-wave peak was detected using a derivative-threshold algorithm, and its occurrence was fixed using parabolic interpolation. The T-wave end was located according to a threshold on the absolute first derivative set as a fraction (i.e., 30%) of the absolute maximal first derivative value computed on the T-wave downslope (29) . The temporal distance between R-wave peak and T-wave end (RTe) was taken as an approximation of QT interval automatically measured from the ECG recording (30) . All R-wave peak detections were carefully checked. Erroneous identifications were corrected and missed beats were manually inserted. Figure 1 shows that although m RR was similar among SMCs and NMCs, it was longer in AMCs ( Figure 1A) . As expected, both AMCs and SMCs had longer m RTe than NMCs ( Figure 1B) . Analysis of RR variability revealed no significant differences between the 3 groups ( Figures 1C and 1E) . RTe decreased during nighttime in AMCs, whereas it did not change in SMCs ( Figure 2D ). During daytime, s 2 RTe was larger in AMCs than in SMCs, whereas no difference was observed during nighttime ( Figure 2D ). HFa RR ( Figure 2E ) and LFa RTe ( Figure 2F ) confirmed the differences observed in Figures 2C and 2D , respectively, and suggested a greater reactivity of the vagal control of heart rate in SMCs and of the sympathetic control of the QT interval in AMCs.
EFFECT OF BETA-BLOCKERS. Figure 3A shows that BB therapy lengthened m RR in both groups, but elongated m RTe only in SMCs ( Figure 3B) . Further, bradycardia induced by BBs was significantly greater in AMCs than in SMCs ( Figure 3A) . BB therapy significantly increased s Figure 3D ). HFa RR ( Figure 3E ) and LFa RTe ( Figure 3F) confirmed the differences observed in Figures 3C and 3D, respectively, and corroborated that, in 
DISCUSSION
The present study significantly extends our previous work, which identified differences in autonomic responses, especially in vagal reflexes, between patients with LQT1 with and without cardiac events (11, 12) . The main novel finding here is the previously unsuspected fact that AMCs have a greater degree of sympathetic modulation directed to the ventricles than SMCs, and this is especially evident in daytime, when the arrhythmic risk for patients with LQT1 is higher (14) . Contrary to common wisdom, this finding-which is directly associated with a higher variability of the QT interval-suggests that a greater sympathetic drive to the ventricles is a protective factor in LQT1. These new observations make an important contribution to our understanding of the physiological mechanisms underlying the otherwise puzzling phenomenon of patients carrying the same disease-causing mutation but with much lower arrhythmic risk (Central Illustration).
Additionally, we observed greater reactivity of the sympathetic control of the QT interval and lesser reactivity of the vagal regulation of heart rate in AMCs compared with SMCs. Indeed, markers of sympathetic modulation derived from QT interval variability in AMCs decreased during nighttime or on BB therapy, whereas they were unmodified in SMCs. AUTONOMIC CONTROL OF HEART RATE. AMCs tended to have lower baseline heart rates, as reported previously (25) , but the difference was significant only compared with NMCs. During daytime, time and frequency domain indexes derived from heart rate variability did not distinguish SMCs from AMCs.
Circadian changes in heart rate were present in both the AMCs and SMCs, but nighttime RR variability was significantly greater only in the SMCs. In addition, the RR interval variability was greater in the SMCs than in the AMCs in response to BBs. Overall, the data pointed to greater vagally mediated RR control in SMCs, thus increasing the likelihood of abrupt changes in the RR interval that would produce a proarrhythmic effect in patients with LQT1. These data fit with and extend our previous observations (11, 12) . The extension is mainly the consequence of the evaluation of frequency domain heart rate variability parameters computed from 24-h Holter recordings in individuals both BBon and BBoff. We observed larger increases in heart rate variability power in the HF band, a widely recognized index of vagal modulation directed to the sinus node (15, (18) (19) (20) , during nighttime and under BB therapy in SMCs compared with AMCs. This supports the conclusion that SMCs show greater reactivity in the vagal control of heart rate compared with AMCs and that a sluggish vagal responsiveness to challenges is a protective factor in LQT1. Figure 1 . The effect of BB therapy, assessed by internal control analysis, also provided interesting data. As expected, the RR interval increased significantly in both groups, but once again, the more interesting finding came from the analysis of RTe variability.
The magnitude of the RTe changes was significantly reduced in the AMCs, whereas it was unmodified in the SMCs, largely because it was already very low. Patients with LQT1 can, rather confidently, be stratified at low arrhythmic risk if they have a relatively low heart rate at rest, a relatively low baroreflex sensitivity, a sluggish heart rate reduction at the end of an exercise stress test, and, as shown here, active sympathetic control of ventricular repolarization and reduced vagal control of heart rate ( Table 1) Autonomic Control in LQT1
